Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): a multicentre, open-label, randomised, phase 3a trial
Diabetologia 48 (4), 612615
GLP-1 medications encourage better eating habits, promote portion control, and reduce overeating, all of which help decrease food waste
Review Article Abstract Introduction Retatrutide for Treatment of Obesity Retatrutide for Treatment of Type 2 Diabetes Effects of Retatrutide on Cardiovascular Risk Factors Safety of Retatrutide Effect of Retatrutide on Heart Rate Advantages of Retatrutide Limitations of Retatrutide Conclusions and Current Needs References Effect of Retatrutide on Heart Rate Increase in heart rate, of approximately 2-6 beats per minute (bpm) compared with placebo, was observed with use of all GLP-1 receptor agonists and with the dual GLP-1/GIP receptor agonist tirzepatide [6-11]
Early demand for that pill has been stronger than expected, with Novo reporting more than 600,000 prescriptions in March
Unlike GIP, the action of GLP-1 is preserved in patients with type 2 diabetes